ALXONasdaqPharmaceutical Preparations

ALX Oncology Holdings Inc (ALXO) earnings date, market-implied expected move, and options open interest by expiry

1.29

pre 1.30 −5.38%

Pre-market16:00 ETdelayed

Open1.37Volume1.6MMkt cap$189.4MEPS-1.13

Day1.28 – 1.3718%52-wk0.86 – 2.6624%

ALXO

ALX Oncology Holdings Inc

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

Next report

Nov 6

before open · in 2 days

est.Q3 FY26

Calendar

Next report

Last report

+9.90%

vs ±51.4% implied · ×0.19

shaded = implied · ▲▼ = realized

Aug 6 '26 · confirmed

Implied vs realized

Linked news

1dJAZZ · supplierJazz Pharmaceuticals posts net loss of $483.4 million for Q3; nine-month net income $2.5 million
4dUSB · supplierU.S. Bancorp sells 1,000,000 depositary shares of Series P preferred
4dSNY · supplierSanofi Q3 sales €14,444 million, business EPS €3.55; upgrades 2026 guidance

News

Largest filed tie

13F top-10 QoQ

+0.27%

shares held · 10 largest managers

13F · Jun 30 '26127d lag

94 managers

Top fund weight

0.01%

ALXO weight · IWM

N-PORTJun 30 '26

3 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

ALX Oncology (ALXO) is expected to report on Nov 6 before open (estimated date).

Implied vs realized

1 report

—≥ implied

Q2 FY26Aug 6 '26confirmed±51.4%▲+9.90%×0.19

quarterimplied−55%0+55%realized×

Q2 FY26±51.4%▲+9.90%×0.19

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 2 expiries · Nov 3 close

0.03OI · 2 expiries · Nov 3 closeP/C open interest · Nov 20 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

53+1667%Nov 2016d1,537+32%

840%Jan 1572d0.042,2220%0.04

ExpiryPutsCallsP/C

Nov 2016d53+1667%1,537+32%0.03

Jan 1572d840%2,2220%0.04

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

No implied move.

Linked exposure

Revenue flow

No filed income statement.

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 16:00 ET

Intraday

Event sensitivity

PPI ×1.11· ±5.3% vs ±4.7% · 10 releases

eventrelease day|move|up · n×base

PPIproducer prices±5.3%4 of 10×1.11

CPROFcorporate profits±4.6%4 of 12×0.96

PCEpersonal income & outlays±4.3%10 of 19×0.91

GDPgross domestic product±4.2%9 of 19×0.89

NFPjobs report±3.8%5 of 10×0.81

CPIconsumer prices±3.6%5 of 10×0.75

FOMCrate decision±3.4%9 of 24×0.72

Bar = avg |move| to ±6% · tick = ±4.7% avg day · ×base = |move| ÷ ±4.7% · min 6 releases

Earnings history

EPS -0.13 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	Aug 6 '26 · confirmed	-0.13	—
Q1 FY26	—	-0.17	—
Q3 FY25	—	-0.41	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod